MONTE CARLO, Monaco--(BUSINESS WIRE)--Join us and witness presentations by more than 175 emerging growth biotechnology companies at an event that rapidly has become the premier event on the Life Sciences calendar. Companies will share their accomplishments on an array of therapeutic topics including oncology, cardiovascular disease, central nervous system disorders, infectious diseases and medical device technology. The Conference offers emerging life sciences companies a unique platform to command the attention of industry-leading institutional investors, venture capitalists, sophisticated private investors, and business development & partnering executives.
